FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

Expedited Licensure Options for Evacuees from Puerto Rico
October 30, 2017

The Board of Pharmacy provides the following information to assist individuals from Puerto Rico who are seeking to work in the state of Florida Continue reading


Urgent National Drug Shortage
October 16, 2017

Please Click for Details on the Urgent National Drug Shortage: Lidocaine with Epinephrine and Bupivacaine with Epinephrine Continue reading